Sign Out
It is recommended that treatment with Tambocor should be initiated in hospital.
a) AV nodal reciprocating tachycardia, Wolff-Parkinson-White syndrome and similar conditions with accessory pathway and anterograde or retrograde conduction.
b) Paroxysmal atrial fibrillation in patients with disabling symptoms. Arrhythmias of recent onset will response more readily.
c) Symptomatic sustained ventricular tachycardia.
d) Premature ventricular contractions and/or non-sustained ventricular tachycardia which are causing disabling symptoms, where these are resistant to other therapy or when other treatment has not been tolerated.
Tambocor tablets can be used for the maintenance of normal rhythm following conversion by other means.
Continue with Google